Copyright Reports & Markets. All rights reserved.

Global Premature Labor Treatment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Premature Labor Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Premature Labor Treatment Market Size Growth Rate by Product
      • 1.4.2 Progesterone
      • 1.4.3 OBE-022
      • 1.4.4 Retosiban
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Premature Labor Treatment Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Premature Labor Treatment Market Size
      • 2.1.1 Global Premature Labor Treatment Revenue 2014-2025
      • 2.1.2 Global Premature Labor Treatment Sales 2014-2025
    • 2.2 Premature Labor Treatment Growth Rate by Regions
      • 2.2.1 Global Premature Labor Treatment Sales by Regions
      • 2.2.2 Global Premature Labor Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Premature Labor Treatment Sales by Manufacturers
      • 3.1.1 Premature Labor Treatment Sales by Manufacturers
      • 3.1.2 Premature Labor Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Premature Labor Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Premature Labor Treatment Revenue by Manufacturers
      • 3.2.1 Premature Labor Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Premature Labor Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Premature Labor Treatment Price by Manufacturers
    • 3.4 Premature Labor Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Premature Labor Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Premature Labor Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Premature Labor Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Premature Labor Treatment Sales by Product
    • 4.2 Global Premature Labor Treatment Revenue by Product
    • 4.3 Premature Labor Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Premature Labor Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Premature Labor Treatment by Countries
      • 6.1.1 North America Premature Labor Treatment Sales by Countries
      • 6.1.2 North America Premature Labor Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Premature Labor Treatment by Product
    • 6.3 North America Premature Labor Treatment by End User

    7 Europe

    • 7.1 Europe Premature Labor Treatment by Countries
      • 7.1.1 Europe Premature Labor Treatment Sales by Countries
      • 7.1.2 Europe Premature Labor Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Premature Labor Treatment by Product
    • 7.3 Europe Premature Labor Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Premature Labor Treatment by Countries
      • 8.1.1 Asia Pacific Premature Labor Treatment Sales by Countries
      • 8.1.2 Asia Pacific Premature Labor Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Premature Labor Treatment by Product
    • 8.3 Asia Pacific Premature Labor Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Premature Labor Treatment by Countries
      • 9.1.1 Central & South America Premature Labor Treatment Sales by Countries
      • 9.1.2 Central & South America Premature Labor Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Premature Labor Treatment by Product
    • 9.3 Central & South America Premature Labor Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Premature Labor Treatment by Countries
      • 10.1.1 Middle East and Africa Premature Labor Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Premature Labor Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Premature Labor Treatment by Product
    • 10.3 Middle East and Africa Premature Labor Treatment by End User

    11 Company Profiles

    • 11.1 AMAG Pharmaceuticals Inc
      • 11.1.1 AMAG Pharmaceuticals Inc Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 AMAG Pharmaceuticals Inc Premature Labor Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 AMAG Pharmaceuticals Inc Premature Labor Treatment Products Offered
      • 11.1.5 AMAG Pharmaceuticals Inc Recent Development
    • 11.2 GlaxoSmithKline Plc
      • 11.2.1 GlaxoSmithKline Plc Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 GlaxoSmithKline Plc Premature Labor Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 GlaxoSmithKline Plc Premature Labor Treatment Products Offered
      • 11.2.5 GlaxoSmithKline Plc Recent Development
    • 11.3 Juniper Pharmaceuticals Inc
      • 11.3.1 Juniper Pharmaceuticals Inc Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Juniper Pharmaceuticals Inc Premature Labor Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Juniper Pharmaceuticals Inc Premature Labor Treatment Products Offered
      • 11.3.5 Juniper Pharmaceuticals Inc Recent Development
    • 11.4 Kissei Pharmaceutical Co Ltd
      • 11.4.1 Kissei Pharmaceutical Co Ltd Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Kissei Pharmaceutical Co Ltd Premature Labor Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Kissei Pharmaceutical Co Ltd Premature Labor Treatment Products Offered
      • 11.4.5 Kissei Pharmaceutical Co Ltd Recent Development
    • 11.5 Lipocine Inc
      • 11.5.1 Lipocine Inc Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Lipocine Inc Premature Labor Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Lipocine Inc Premature Labor Treatment Products Offered
      • 11.5.5 Lipocine Inc Recent Development
    • 11.6 ObsEva SA
      • 11.6.1 ObsEva SA Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 ObsEva SA Premature Labor Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 ObsEva SA Premature Labor Treatment Products Offered
      • 11.6.5 ObsEva SA Recent Development

    12 Future Forecast

    • 12.1 Premature Labor Treatment Market Forecast by Regions
      • 12.1.1 Global Premature Labor Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Premature Labor Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Premature Labor Treatment Market Forecast by Product
      • 12.2.1 Global Premature Labor Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Premature Labor Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Premature Labor Treatment Market Forecast by End User
    • 12.4 North America Premature Labor Treatment Forecast
    • 12.5 Europe Premature Labor Treatment Forecast
    • 12.6 Asia Pacific Premature Labor Treatment Forecast
    • 12.7 Central & South America Premature Labor Treatment Forecast
    • 12.8 Middle East and Africa Premature Labor Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Premature Labor Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Premature Labor Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Premature Labor Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Premature Labor Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Premature Labor Treatment in these regions.
      This research report categorizes the global Premature Labor Treatment market by top players/brands, region, type and end user. This report also studies the global Premature Labor Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      AMAG Pharmaceuticals Inc
      GlaxoSmithKline Plc
      Juniper Pharmaceuticals Inc
      Kissei Pharmaceutical Co Ltd
      Lipocine Inc
      ObsEva SA

      Market size by Product
      Progesterone
      OBE-022
      Retosiban
      Others
      Market size by End User
      Hospital
      Clinic
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Premature Labor Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Premature Labor Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Premature Labor Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Premature Labor Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Premature Labor Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Premature Labor Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now